Raymond J. Henley Iii

Array ( [id] => 3947032 [patent_doc_number] => 05977158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Pharmaceutical formulations comprising levormeloxifene compounds' [patent_app_type] => 1 [patent_app_number] => 8/976704 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4273 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977158.pdf [firstpage_image] =>[orig_patent_app_number] => 976704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3913530 [patent_doc_number] => 06001864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Antifungal agent' [patent_app_type] => 1 [patent_app_number] => 8/952433 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4165 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001864.pdf [firstpage_image] =>[orig_patent_app_number] => 952433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935955 [patent_doc_number] => 05989593 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Method for producing antithrombin-III, method for purifying it, and preparation containing it' [patent_app_type] => 1 [patent_app_number] => 8/974191 [patent_app_country] => US [patent_app_date] => 1997-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7088 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989593.pdf [firstpage_image] =>[orig_patent_app_number] => 974191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003004 [patent_doc_number] => 05859000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method for reducing mast cell mediated allergic reactions' [patent_app_type] => 1 [patent_app_number] => 8/966385 [patent_app_country] => US [patent_app_date] => 1997-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 15595 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 566 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859000.pdf [firstpage_image] =>[orig_patent_app_number] => 966385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238828 [patent_doc_number] => 06166090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 8/965589 [patent_app_country] => US [patent_app_date] => 1997-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17873 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166090.pdf [firstpage_image] =>[orig_patent_app_number] => 965589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925454 [patent_doc_number] => 05945456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 8/965254 [patent_app_country] => US [patent_app_date] => 1997-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7846 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945456.pdf [firstpage_image] =>[orig_patent_app_number] => 965254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044350 [patent_doc_number] => 05874471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection' [patent_app_type] => 1 [patent_app_number] => 8/961639 [patent_app_country] => US [patent_app_date] => 1997-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9567 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874471.pdf [firstpage_image] =>[orig_patent_app_number] => 961639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064900 [patent_doc_number] => 05866590 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation' [patent_app_type] => 1 [patent_app_number] => 8/945585 [patent_app_country] => US [patent_app_date] => 1997-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3831 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866590.pdf [firstpage_image] =>[orig_patent_app_number] => 945585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3921122 [patent_doc_number] => 05876738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Antifungal phyllosilicate' [patent_app_type] => 1 [patent_app_number] => 8/957337 [patent_app_country] => US [patent_app_date] => 1997-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6586 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876738.pdf [firstpage_image] =>[orig_patent_app_number] => 957337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010131 [patent_doc_number] => 05962454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Neovascularization inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/945492 [patent_app_country] => US [patent_app_date] => 1997-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5593 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962454.pdf [firstpage_image] =>[orig_patent_app_number] => 945492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3958389 [patent_doc_number] => 05900255 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Material for prevention and treatment of osteoporosis' [patent_app_type] => 1 [patent_app_number] => 8/954744 [patent_app_country] => US [patent_app_date] => 1997-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2835 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900255.pdf [firstpage_image] =>[orig_patent_app_number] => 954744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4198545 [patent_doc_number] => 06013621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Method of treating psychosis and/or hyperactivity' [patent_app_type] => 1 [patent_app_number] => 8/953442 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14268 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013621.pdf [firstpage_image] =>[orig_patent_app_number] => 953442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3817069 [patent_doc_number] => 05789537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Method for preparing streptogramins' [patent_app_type] => 1 [patent_app_number] => 8/930135 [patent_app_country] => US [patent_app_date] => 1997-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2100 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789537.pdf [firstpage_image] =>[orig_patent_app_number] => 930135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868899 [patent_doc_number] => 05824294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Sand removing body powder' [patent_app_type] => 1 [patent_app_number] => 8/950689 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1383 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824294.pdf [firstpage_image] =>[orig_patent_app_number] => 950689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087142 [patent_doc_number] => 06025399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Method of producing neuromuscular block by the use of tetra-propyl or tetrabutylammonium compounds' [patent_app_type] => 1 [patent_app_number] => 8/950633 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2711 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025399.pdf [firstpage_image] =>[orig_patent_app_number] => 950633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871561 [patent_doc_number] => 05763414 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/949669 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2528 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763414.pdf [firstpage_image] =>[orig_patent_app_number] => 949669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045833 [patent_doc_number] => 05908834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Partricin derivatives in the prophylactic and/or curative treatment of fungal contamination of cell cultures and of tissues' [patent_app_type] => 1 [patent_app_number] => 8/950142 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 4045 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908834.pdf [firstpage_image] =>[orig_patent_app_number] => 950142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937464 [patent_doc_number] => 05972919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof' [patent_app_type] => 1 [patent_app_number] => 8/944683 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1953 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972919.pdf [firstpage_image] =>[orig_patent_app_number] => 944683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024473 [patent_doc_number] => 05993863 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Alimentative infusion liquids for administration through peripheral vein' [patent_app_type] => 1 [patent_app_number] => 8/946359 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6413 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993863.pdf [firstpage_image] =>[orig_patent_app_number] => 946359 [rel_patent_id] =>[rel_patent_doc_number] =>)